Chair, Department of Epidemiology & Population Health
Harold and Muriel Block Chair in Epidemiology & Population Health
Leader, Cancer Epidemiology Program, Albert Einstein Cancer Center
Associate Director for Population Sciences, Albert Einstein Cancer Center
Scientific Director, Epidemiology Study Management and Informatics Shared Facility, Albert Einstein Cancer Center
Dr. Rohan is a cancer epidemiologist who studies the role of genetic/molecular, nutritional, and hormonal factors in the etiology and pathogenesis of a wide range of cancers. Much of his work has focused on breast cancer, in relation to which he has a particular interest in the molecular pathogenesis of breast cancer, where his work focuses on identifying molecular changes in benign breast disease tissue that predispose to the development of subsequent breast cancer. Many of his other studies have involved cohort investigations, mostly within the Women’s Health Initiative cohorts, the Canadian National Breast Screening Study dietary cohort, and more recently within a new cohort that he established, the Canadian Study of Diet, Lifestyle, and Health. He has published many scientific articles on cancer epidemiology, and he has co-edited books on cancer precursors and on cervical cancer.
In addition to being chair of the department of epidemiology and population health, Dr. Rohan is associate director for population sciences in the Albert Einstein Cancer Center, and he is a member of the Board of Scientific Counselors of the National Cancer Institute. He is on the editorial board of several journals, and is a member of several professional societies.
More Information About Dr. Thomas Rohan
Material in this section is provided by individual faculty members who are solely responsible for its accuracy and content.
Albert Einstein College of Medicine
Jack and Pearl Resnick Campus
1300 Morris Park Avenue
Belfer Building, Room 1301
Bronx, NY 10461
NBCNews.com reports on new research by Drs. Thomas Rohan and Geoffrey Kabat that suggests taller postmenopausal woman are at greater risk of developing cancer.